Mithat Gunduz

711 total citations
24 papers, 551 citations indexed

About

Mithat Gunduz is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Mithat Gunduz has authored 24 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in Mithat Gunduz's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Computational Drug Discovery Methods (3 papers). Mithat Gunduz is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Computational Drug Discovery Methods (3 papers). Mithat Gunduz collaborates with scholars based in United States, Switzerland and China. Mithat Gunduz's co-authors include Upendra A. Argikar, Mary Jeanne Kreek, James H. Schluger, Andrea C. King, R. Scott Obach, Shawn Harriman, Christopher L. Shaffer, L.A.H. Borg, A. Ho and Franco Lombardo and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Life Sciences and Journal of Pharmaceutical Sciences.

In The Last Decade

Mithat Gunduz

22 papers receiving 531 citations

Peers

Countries citing papers authored by Mithat Gunduz

Since Specialization

Citations

This map shows the geographic impact of Mithat Gunduz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mithat Gunduz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mithat Gunduz more than expected).

Fields of papers citing papers by Mithat Gunduz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mithat Gunduz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mithat Gunduz. The network helps show where Mithat Gunduz may publish in the future.

Co-authorship network of co-authors of Mithat Gunduz

This figure shows the co-authorship network connecting the top 25 collaborators of Mithat Gunduz. A scholar is included among the top collaborators of Mithat Gunduz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mithat Gunduz. Mithat Gunduz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations 2023 ·Drug Metabolism and Disposition ·Minxia M. He, Xiaochun Zhu, Joe R. Cannon, (unknown), Ruchia Duggal, Mithat Gunduz, Constanze Hilgendorf, Adam D. Hughes, (unknown), (unknown), Dennis Leung, (unknown), Kai Wang, Frank Wesche	7
2	Models and Approaches Describing the Metabolism, Transport, and Toxicity of Drugs Administered by the Ocular Route 2018 ·Drug Metabolism and Disposition ·(unknown), Nagendra Chemuturi, Mark Milton, Gian Camenisch, James E. Chastain, Markus Walles, Vito G. Sasseville, Mithat Gunduz, (unknown), Upendra A. Argikar	14
3	Investigation of Ocular Bioactivation Potential and the Role of Cytochrome P450 2D Enzymes in Rat 2018 ·Drug Metabolism Letters ·(unknown), Upendra A. Argikar, (unknown), (unknown), Christine E. Dunne, Valerie M. Kramlinger, (unknown), Mithat Gunduz	2
4	Do We Need to Study Metabolism and Distribution in the Eye: Why, When, and Are We There Yet? 2017 ·Journal of Pharmaceutical Sciences ·Upendra A. Argikar, (unknown), Valerie M. Kramlinger, (unknown), Mithat Gunduz, Christine E. Dunne, Bindi Sohal	17
5	In vitro ocular metabolism and bioactivation of ketoconazole in rat, rabbit and human 2016 ·Drug Metabolism and Pharmacokinetics ·(unknown), (unknown), Mithat Gunduz, Christine E. Dunne, Upendra A. Argikar	13
6	Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 2: Clearance 2012 ·The Journal of Clinical Pharmacology ·Franco Lombardo, Nigel J. Waters, Upendra A. Argikar, Michelle K. Dennehy, Jenny Zhan, Mithat Gunduz, Shawn Harriman, Giuliano Berellini, (unknown), R. Scott Obach	72
7	Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 1: Volume of Distribution at Steady State 2012 ·The Journal of Clinical Pharmacology ·Franco Lombardo, Nigel J. Waters, Upendra A. Argikar, Michelle K. Dennehy, Jenny Zhan, Mithat Gunduz, Shawn Harriman, Giuliano Berellini, (unknown), R. Scott Obach	57
8	Oxidative ipso Substitution of 2,4-Difluoro-benzylphthalazines: Identification of a Rare Stable Quinone Methide and Subsequent GSH Conjugate 2012 ·Drug Metabolism and Disposition ·Mithat Gunduz, Upendra A. Argikar, Amin Kamel, (unknown), (unknown), (unknown), Franco Lombardo, Shawn Harriman	10
9	A new structural alert for benzimidazoles: 2,6-Dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition risk 2011 ·Bioorganic & Medicinal Chemistry Letters ·Young‐Shin Kwak, Gary M. Coppola, Cornelia J. Forster, (unknown), (unknown), (unknown), Alan D. Neubert, (unknown), (unknown), Susanne Glowienke, (unknown), (unknown), (unknown), Eric T. Gangl, Mithat Gunduz, Monish Jain, Jenny Zhan, Michael H. Serrano‐Wu	0
10	In vitro-in vivocorrelation for intrinsic clearance for CP-409,092 and sumatriptan: a case study to predict thein vivoclearance for compounds metabolized by monoamine oxidase 2011 ·Xenobiotica ·Amin Kamel, (unknown), Mithat Gunduz, Shawn Harriman, R. Scott Obach	10
11	Identification of a Novel N-Carbamoyl Glucuronide: In Vitro, In Vivo, and Mechanistic Studies 2009 ·Drug Metabolism and Disposition ·Mithat Gunduz, Upendra A. Argikar, Daniel K. Baeschlin, Suzie A. Ferreira, Vinayak Hosagrahara, Shawn Harriman	28
12	Species Differences in the Biotransformation of an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist: The Effects of Distinct Glucuronide Metabolites on Overall Compound Disposition 2009 ·Drug Metabolism and Disposition ·Christopher L. Shaffer, Mithat Gunduz, Tim F. Ryder, Thomas N. O’Connell	5
13	Metabolism and Disposition of a γ-Aminobutyric Acid Type A Receptor Partial Agonist in Humans 2008 ·Drug Metabolism and Disposition ·Christopher L. Shaffer, Mithat Gunduz, Alfin D. N. Vaz, Karthik Venkatakrishnan, Aaron H. Burstein	3
14	Metabolism and Disposition of a Selective α7 Nicotinic Acetylcholine Receptor Agonist in Humans 2007 ·Drug Metabolism and Disposition ·Christopher L. Shaffer, Mithat Gunduz, Renato J. Scialis, Annie Fang	22
15	Using a Tritiated Compound to Elucidate Its Preclinical Metabolic and Excretory Pathways in Vivo: Exploring Tritium Exchange Risk 2006 ·Drug Metabolism and Disposition ·Christopher L. Shaffer, Mithat Gunduz, Bruce A. Thornburgh, Gwendolyn D. Fate	22
16	BIOTRANSFORMATION OF A GABAA RECEPTOR PARTIAL AGONIST IN SPRAGUE-DAWLEY RATS AND CYNOMOLGUS MONKEYS: IDENTIFICATION OF TWO UNIQUE N-CARBAMOYL METABOLITES 2005 ·Drug Metabolism and Disposition ·Christopher L. Shaffer, Mithat Gunduz, Thomas N. O’Connell, R. Scott Obach, Shiyin Yee	29
17	Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions 1999 ·Journal of Pharmacology and Experimental Therapeutics ·Mary Jeanne Kreek, James H. Schluger, L.A.H. Borg, Mithat Gunduz, A. Ho	75
18	Nalmefene Causes Greater Hypothalamic‐Pituitary‐Adrenal Axis Activation than Naloxone in Normal Volunteers: Implications for the Treatment of Alcoholism 1998 ·Alcoholism Clinical and Experimental Research ·James H. Schluger, Ann Ho, Lisa Borg, (unknown), (unknown), Mithat Gunduz, (unknown), Andrea C. King, Mary Jeanne Kreek	78
19	Basal total opioid peptide release in the striatum of rats with cholestasis from bile duct resection: A study by the use of in vivo microdialysis. 1997 ·Life Sciences ·Nora V. Bergasa, (unknown), I.M. Maisonneuve, Ann Ho, Nigel T. Maidment, M. Foster Olive, Mithat Gunduz, M J Kreek	7
20	Naltrexone Biotransformation and Incidence of Subjective Side Effects: A Preliminary Study 1997 ·Alcoholism Clinical and Experimental Research ·Andrea C. King, Joseph R. Volpicelli, Mithat Gunduz, Charles P. O’Brien, Mary Jeanne Kreek	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact